Syantra, Inc., has recently completed new patent filings that expand previous work in cancer molecular diagnostics to encompass new drug targets and therapeutics.

Another Roundup trial began on Tuesday in Missouri.

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will provide a corporate update and ...

PE presently has two primary entries into the U.S. legal industry: via alternative business structures in Arizona or managed ...

The approval of ATZUMI and BREKIYA is expected to significantly reshape the migraine market by introducing new, innovative treatment options.

Visit a quote page and your recently viewed tickers will be displayed here.